Heart Failure Flashcards

Module 3

1
Q

What are 4 classifications of cardiomyopathy?

A

Dilated CM, hypertrophic CM, restrictive CM, and arrhythmogenic CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common cause of HF?

A

Cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 2 main types of HF?

A

HFrEF (EF <40%) and HFpEF (EF >40%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which type of HF is common in older women?

A

HFpEF (EF >40%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HFrEF is caused by a reduction in

A

The contractility of the left ventricle (systolic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Neurohormonal overexpression in HF causes activation of

A

Adrenergic nervous system and renin-angiotensin system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HFpEF is associated with

A

Impairment of ventricular filling and relaxation (diastolic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Activation of the RAAS causes retention of

A

Sodium and water leading to decreased renal perfusion and increased BUN/Cr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are 6 causes of HF?

A

Cardiotoxic medications, autoimmune disorders, familial CMO, infiltrative heart disease (amyloidosis), stress cardiomyopathy (Takotsubo), and substance use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are symptoms of HF?

A

Dyspnea, fatigue, lower extremity edema, JVD, paroxysmal nocturnal dyspnea, SOB with exertion or at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is characteristic of amyloidosis?

A

Protein deposits in organ tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

According to ACC/AHA guidelines, describe the 4 stages of HF

A

Stage A: at risk for HF
Stage B: pre-HF
Stage C: symptomatic HF
Stage D: advanced HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

According to NYHA functional classification, describe the 4 stages of HF

A

Class I: asymptomatic
Class II: mild
Class III: moderate
Class IV: severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which disease is an under diagnosed cause of HF?

A

Amyloidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Amyloidosis should be considered in patients with

A

HFpEF, low-voltage EKG, and hypertrophy on echo (but not on EKG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are diagnostic tests that can be done for HF?

A

Echo, chest x-ray, EKG, cardiac catheterization, cardiac MRI, PET/CT, and exercise tolerance testing

17
Q

A cardiac MRI would be helpful in ruling out

A

Amyloidosis or cardiomyopathy

18
Q

BNP and NT-proBNP promote

A

Vasodilation, diuresis, and regulation of cardiac remodeling

19
Q

What should be assessed for in the physical exam when suspecting HF?

A

JVD, narrow pulse pressure, apical pulse displacement, S3 gallop (indicates fluid overload), cardiac murmur, adventitious lung sounds, and edema

20
Q

Name 5 differential diagnoses for HF

A

Mechanical obstruction, COPD, asthma and URI, pleural effusion, pulmonary emboli

21
Q

BNP levels may be increased with

A

Age, ACS, atrial fibrillation, anemia, COPD, pulmonary HTN, pneumonia, sepsis, valvular disease, and renal dysfunction

22
Q

BNP levels may be decreased with

A

Obesity

23
Q

What labs should be evaluated when diagnosing HF?

A

CBC
Serum electrolytes (calcium and magnesium)
Urinalysis
Albumin

24
Q

Which CBC results can exacerbate HF?

A

Anemia, IDA, or iron overload

25
Q

What electrolyte can be affected with fluid overload and diuretics?

A

Sodium (decreased)

26
Q

Proteinuria can be evidence of

A

Renal disease

27
Q

What albumin level may cause edema?

A

Decreased levels

28
Q

What medications can be used in the treatment of HF?

A

ACEIs, ARBs, BBs, Hydralazine, nitrates, Aldosterone, diuretics, Digoxin, CCBs, inotropics

29
Q
A